Caregivers Weigh In On CMS Insulin Pump Coverage: C-peptide Test Must Go
This article was originally published in The Gray Sheet
Executive Summary
CMS should eliminate its requirement that all patients seeking coverage for insulin pumps demonstrate abnormally low C-peptide levels, according to the American Association of Clinical Endocrinologists